Protagonist Therapeutics PTGX Business Segments — Segment Reporting Other Item Amount
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's business segments — segment reporting other item amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's business segments — segment reporting other item amount?
- Protagonist Therapeutics (PTGX) reported business segments — segment reporting other item amount of -$53K in Q1 2026.
- How has Protagonist Therapeutics's business segments — segment reporting other item amount changed year-over-year?
- Protagonist Therapeutics's business segments — segment reporting other item amount increased by 35.4% year-over-year, from -$82K to -$53K.
- What is the long-term trend for Protagonist Therapeutics's business segments — segment reporting other item amount?
- Over 2 years (2022 to 2024), Protagonist Therapeutics's business segments — segment reporting other item amount has grown at a 76.8% compound annual growth rate (CAGR), from $80K to -$250K.
- What does business segments — segment reporting other item amount mean?
- This captures miscellaneous income or expense items that do not fit into the primary operating categories of the business segment. It may include non-recurring gains, losses, or adjustments that impact the segment's overall financial performance. Tracking this helps isolate core operational results from irregular or incidental financial events.